| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K61166597 |
| PharmacoGx | BRD-K61166597 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CTDSPL2 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | NFAT5 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | TOR1B | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | FAM160A2 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | USP45 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | AC138969.4 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | NUP155 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | DAD1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | LETMD1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | VEGFD | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
